Treatment of children living with HIV
©WHO / Christopher Black
An estimated 1.7 million children aged 0-14 were living with HIV at the end of 2018, and 160 000 children were newly infected. An estimated 100 000 children died of AIDS-related illnesses. To reduce HIV-related mortality and morbidity among this highly vulnerable population, early testing and treatment is essential. Without access to testing and treatment, 50% of children with HIV will die by the age of 2, and 80% will not live to their fifth birthday.
Latest updates
-
WHO welcomes FDA approval of new formulation of dolutegravir for young children living with HIV
18 June 2020 -
Point-of-care tests for diagnosing HIV infection among children younger than 18 months
April 2020 -
UNAIDS Board puts special focus on children and youth
News update - 16 December 2019 -
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
Journal article published in The Lancet HIV - September 2019 -
HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis
Toolkit - July 2019 -
Start Free Stay Free AIDS Free - 2019 report
UNAIDS - July 2019, PDF, 3Mb
Meeting
Technical documents
Data and statistics
General information
-
Renewed action needed to end HIV among children in West and Central Africa
January 2019 -
A new push for timely diagnosis and treatment of children with HIV
EGPAF and WHO statement - December 2018 -
Global partners commit to speed up access to treatment for children with HIV
November 2017 -
Two cutting-edge technologies for HIV detection in infants receive WHO prequalification
June 2016